Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche

J Clin Oncol. 2020 Nov 10;38(32):3816-3818. doi: 10.1200/JCO.20.02351. Epub 2020 Sep 18.

Authors

Paul J Bröckelmann¹, Sven Borchmann¹, Peter Borchmann¹, Andreas Engert¹

Affiliation

¹ Department I of Internal Medicine, Center for Integrated Oncology, Aachen Bonn Cologne Duesseldorf, and German Hodgkin Study Group, University of Cologne, Cologne, Germany.

PMID: 32946351
DOI: 10.1200/JCO.20.02351

No abstract available

MeSH terms

Antigens, CD19 / immunology*
Hodgkin Disease / immunology
Hodgkin Disease / therapy*
Humans
Immunotherapy, Adoptive / methods*
Ki-1 Antigen / immunology*
Receptors, Antigen, T-Cell / immunology*
Receptors, Chimeric Antigen / immunology*

Substances

Antigens, CD19
CD19 molecule, human
Ki-1 Antigen
Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen